NewsRx

Search our medical news database

Medical Devices

U.S. FDA approves new SurTrak Line of brachytherapy preloaded needle kits

Published in Medical Letter on the CDC and FDA, March 12th, 2006

North American Scientific, Inc. (NASI) announced that the U.S. Food & Drug Administration (FDA) has approved the company's application to market its new Prospera SurTrak line of brachytherapy products for the treatment of prostate cancer.

The new family of products includes the SurTrak preplugged needle with a unique synthetic, microangled insert for improved seed delivery and precise placement. The SurTrak strand, used in conjunction with the needle, is bioresorbable and designed to hold the seeds at predetermined distances adding speed and precision to the prostate brachytherapy procedure.

The new SurTrak needle will also be available preloaded...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook